These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9758052)

  • 1. Spread of vancomycin-resistant enterococci: why did it happen in the United States?
    Martone WJ
    Infect Control Hosp Epidemiol; 1998 Aug; 19(8):539-45. PubMed ID: 9758052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).
    MMWR Recomm Rep; 1995 Sep; 44(RR-12):1-13. PubMed ID: 7565541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spread of vancomycin-resistant enterococci: differences between the United States and Europe.
    Goossens H
    Infect Control Hosp Epidemiol; 1998 Aug; 19(8):546-51. PubMed ID: 9758053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2004 Lowbury Lecture: the Western Australian experience with vancomycin-resistant enterococci - from disaster to ongoing control.
    Pearman JW
    J Hosp Infect; 2006 May; 63(1):14-26. PubMed ID: 16563562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs.
    Austin DJ; Bonten MJ; Weinstein RA; Slaughter S; Anderson RM
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6908-13. PubMed ID: 10359812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units.
    Fridkin SK; Edwards JR; Courval JM; Hill H; Tenover FC; Lawton R; Gaynes RP; McGowan JE;
    Ann Intern Med; 2001 Aug; 135(3):175-83. PubMed ID: 11487484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin-resistant enterococci.
    Rubinstein E; Keynan Y
    Crit Care Clin; 2013 Oct; 29(4):841-52. PubMed ID: 24094380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin-resistant enterococci.
    Palmer SM; Rybak MJ
    Pharmacotherapy; 1996; 16(5):819-29. PubMed ID: 8888077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and control of vancomycin-resistant enterococci in an adult and children's hospital.
    Tucci V; Haran MA; Isenberg HD
    Am J Infect Control; 1997 Oct; 25(5):371-6. PubMed ID: 9343618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci.
    Hayden MK
    Clin Infect Dis; 2000 Oct; 31(4):1058-65. PubMed ID: 11049790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with a hospital-wide outbreak of vancomycin-resistant enterococci.
    Quale J; Landman D; Atwood E; Kreiswirth B; Willey BM; Ditore V; Zaman M; Patel K; Saurina G; Huang W; Oydna E; Burney S
    Am J Infect Control; 1996 Oct; 24(5):372-9. PubMed ID: 8902112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin-resistant enterococci.
    McGeer AJ; Low DE
    Semin Respir Infect; 2000 Dec; 15(4):314-26. PubMed ID: 11220414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications.
    McDonald LC; Kuehnert MJ; Tenover FC; Jarvis WR
    Emerg Infect Dis; 1997; 3(3):311-7. PubMed ID: 9284375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unit.
    Malik RK; Montecalvo MA; Reale MR; Li K; Maw M; Munoz JL; Gedris C; van Horn K; Carnevale KA; Levi MH; Dweck HS
    Pediatr Infect Dis J; 1999 Apr; 18(4):352-6. PubMed ID: 10223689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin-resistant enterococcus. Detection, epidemiology, and control measures.
    Boyce JM
    Infect Dis Clin North Am; 1997 Jun; 11(2):367-84. PubMed ID: 9187952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.
    Salgado CD
    Am J Infect Control; 2008 Dec; 36(10):S175.e5-8. PubMed ID: 19084155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin-resistant enterococci. Mechanism and clinical relevance.
    Eliopoulos GM
    Infect Dis Clin North Am; 1997 Dec; 11(4):851-65. PubMed ID: 9421703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin-resistant-enterococci--colonization of 24 patients on a pediatric oncology unit.
    Schuster F; Graubner UB; Schmid I; Weiss M; Belohradsky BH
    Klin Padiatr; 1998; 210(4):261-3. PubMed ID: 9743963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of subclinical transmission of vancomycin-resistant enterococcus within an intensive care unit in Taiwan.
    Lee SC; Lee CW; Shih TC; See LC; Chu CM; Liu YC
    J Microbiol Immunol Infect; 2016 Oct; 49(5):749-759. PubMed ID: 27156242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).
    Am J Infect Control; 1995 Apr; 23(2):87-94. PubMed ID: 7639408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.